Deficient Expression of the DPD Gene Is Caused by Epigenetic Modification in Biliary Tract Cancer Cells, and Induces High Sensitivity to 5-Fu Treatment

International Journal of Oncology - Greece
doi 10.3892/ijo.29.2.429
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Epigenetic Modification of RhoE Expression in Gastric Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2010English

Annexin A1 Is Involved in Resistance to 5-Fu in Colon Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2016English

Regulation of Estrogen Receptor Β1 Expression in Breast Cancer by Epigenetic Modification of the 5′ Regulatory Region

International Journal of Oncology
Cancer ResearchOncology
2013English

Metformin Increases Chemo-Sensitivity via Gene Downregulation Encoding DNA Replication Proteins in 5-Fu Resistant Colorectal Cancer Cells

Oncotarget
Oncology
2017English

Expression of Lethal Side Effect of 5-Fu Originated From Suicide Inhibition of Metabolic Enzyme DPD of 5-Fu by (E)-5 - ( 2 - Bromovinyl ) Uracil (BVU) Produced From Sorivudine.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1997English

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2020English

EGFR and HER2 Expression in Advanced Biliary Tract Cancer

Zeitschrift fur Gastroenterologie
MedicineGastroenterology
2008English

Epigenetic Silencing of the Sulfate Transporter Gene DTDST Induces Sialyl Lewisx Expression and Accelerates Proliferation of Colon Cancer Cells

Cancer Research
Cancer ResearchOncology
2010English

miR-329 Regulates the Sensitivity of 5-Fu in Chemotherapy of Colorectal Cancer by Targeting E2F1

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy